The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $394,113 in first-year total cost, median $197,057.
Most frequent study sections
- Special Emphasis Panel[ZEY1 VSN (02)]2
Most frequent institutions
- DUKE UNIVERSITY1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2022 | NAC Attack, a phase-3, multicenter, randomized, placebo-controlled trial with retinitis pigmentosa: OCT Reading Center1UG1EY033287-01 | FARSIU, SINAJAFFE, GLENN | DUKE UNIVERSITY, NC | $213,871 | ZEY1 |
| 2022 | NAC Attack AOSLO Reading Center1UG1EY033292-01 | CARROLL, JOSEPHDUNCAN, JACQUE LYNNE | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $180,242 | ZEY1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.